AMRN logo

AMRN
Amarin Corp - ADR

30,582
Mkt Cap
$340.68M
Volume
63,935.00
52W High
$20.90
52W Low
$7.08
PE Ratio
-3.93
AMRN Fundamentals
Price
$16.38
Prev Close
$16.43
Open
$16.45
50D MA
$17.16
Beta
1.23
Avg. Volume
152,084.83
EPS (Annual)
-$4.00
P/B
0.74
Rev/Employee
$831,673.45
Loading...
Loading...
News
all
press releases
Amarin (NASDAQ:AMRN) Stock Price Crosses Above 200 Day Moving Average - Should You Sell?
Amarin (NASDAQ:AMRN) Stock Price Passes Above 200-Day Moving Average - Time to Sell...
MarketBeat·1d ago
News Placeholder
More News
News Placeholder
Quinn Opportunity Partners LLC Sells 1,110,778 Shares of Amarin Corporation PLC $AMRN
Quinn Opportunity Partners LLC trimmed its stake in shares of Amarin Corporation PLC (NASDAQ:AMRN - Free Report) by 95.0% during the second quarter, according to the company in its most recent 13F...
MarketBeat·9d ago
News Placeholder
Amarin (NASDAQ:AMRN) Shares Cross Above 200-Day Moving Average - Should You Sell?
Amarin (NASDAQ:AMRN) Shares Cross Above Two Hundred Day Moving Average - Here's What Happened...
MarketBeat·9d ago
News Placeholder
Amarin's Q3 Earnings Lag Estimates, Revenues Beat, Stock Down
AMRN's third-quarter earnings fall short of expectations, but stronger U.S. Vascepa sales push revenues above estimates.
Zacks·24d ago
News Placeholder
Do Options Traders Know Something About Amarin Stock We Don't?
Investors need to pay close attention to AMRN stock based on the movements in the options market lately.
Zacks·1mo ago
News Placeholder
Are Medical Stocks Lagging Boston Scientific (BSX) This Year?
Here is how Boston Scientific (BSX) and Amarin (AMRN) have performed compared to their sector so far this year.
Zacks·1mo ago
News Placeholder
Amarin (AMRN) Surges 12.5%: Is This an Indication of Further Gains?
Amarin (AMRN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Zacks·2mo ago
News Placeholder
Prothena (PRTA) Up 17.6% Since Last Earnings Report: Can It Continue?
Prothena (PRTA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks·3mo ago
News Placeholder
Is Amarin (AMRN) Stock Outpacing Its Medical Peers This Year?
Here is how Amarin (AMRN) and ANI Pharmaceuticals (ANIP) have performed compared to their sector so far this year.
Zacks·3mo ago
News Placeholder
RCKT Stock Rises as FDA Lifts Clinical Hold on Danon Disease Study
Rocket Pharmaceuticals' shares soar as the FDA lifts its clinical hold on the pivotal Danon disease gene therapy study.
Zacks·3mo ago

Latest AMRN News

View

Advertisement|Remove ads.

Advertisement|Remove ads.